日本小林制药社长和会长辞职，几十名消费者此前疑因服用该公司含红麹成分的保健品死亡。
彭博社报道，小林制药（Kobayashi Pharmaceutical Co.）星期二（7月23日）发布声明称，社长小林章浩及会长小林一雅将辞任，公司专务山根聪将接任社长一职。
小林制药上个月说，正在调查76人因服用含红麹成分保健品死亡的事件。红麹的学名为红麹霉，用于酿造红麹米酒和制作食品已有千余年的历史。
公司股价星期二在东京市场跌1％，今年累计跌幅近18%。
新华社引述日本卫生劳动部长武见敬三5月28日的话说，确认在小林制药公司含红麹成分的保健品原料中检测到的软毛青霉酸（puberulic acid）会对肾脏造成不良影响。除软毛青霉酸外，样品检测还确认了其他两种此前未知的化合物的存在。武见敬三说，推测这些物质都是在培养红麹的过程中混入的青霉菌所产生。
The 2025 US holiday shopping season was supposed to be a double celebration for both merchants and consumers. However, the reality is shrouded in a "bill chill."
The 2025 US holiday shopping season was supposed to be a do…
On November 5th, the US federal government entered its 36th…
JPMorgan Chase CEO Jamie Dimon recently made important asse…
When the US Senate passed a resolution with 51 votes in fav…
Recently, according to Teslarati, Tesla announced that the …
Nikkei Group, the Japanese business information giant that …
© Copyright 2025, All Rights Reserved
